Thus, an increase in the number of NKG2D receptors on sNK cells and increased MICA/B on melanoma tumors during sNK cell interaction could contribute to increased efficacy of sNK cells against melanoma tumors compared to primary NK cells. The gene discussed is MICA; the disease is melanoma.